Hematopoietic Stem Cell TransplantationHematopoietic Stem CellsFetal BloodTransplantation, HomologousStem Cell TransplantationCord Blood Stem Cell TransplantationTransplantation ConditioningTransplantation, AutologousGraft vs Host DiseaseAntigens, CD34Stem CellsPeripheral Blood Stem Cell TransplantationHematologic NeoplasmsBone Marrow TransplantationTransplantation ChimeraTissue DonorsTreatment OutcomeHematopoiesisGraft SurvivalMyeloablative AgonistsHistocompatibility TestingWhole-Body IrradiationHematopoietic Stem Cell MobilizationBusulfanHistocompatibilityChimerismGraft vs Leukemia EffectLeukemiaRetrospective StudiesLiver TransplantationRecurrenceCell DifferentiationBone Marrow CellsMesenchymal Stem Cell TransplantationHematologic DiseasesRemission InductionImmunosuppressive AgentsHepatic Veno-Occlusive DiseaseCombined Modality TherapyMultiple MyelomaHLA AntigensCell LineageSiblingsUnrelated DonorsVidarabineCell TransplantationLeukemia, Myeloid, AcuteMyelodysplastic SyndromesStem Cell NicheTime FactorsSurvival RateEmbryonic Stem CellsGraft vs Tumor EffectAdult Stem CellsDisease-Free SurvivalFlow CytometryTransplantation ImmunologySurvival AnalysisMelphalanSevere Combined ImmunodeficiencyKidney TransplantationMice, Inbred C57BLLymphocyte TransfusionBone MarrowTransplantation, IsogeneicCyclophosphamideColony-Forming Units AssayPrecursor Cell Lymphoblastic Leukemia-LymphomaGranulocyte Colony-Stimulating FactorSalvage TherapyCytomegalovirus InfectionsAntilymphocyte SerumLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAnemia, AplasticDonor SelectionAllograftsFollow-Up StudiesLymphocyte DepletionT-LymphocytesAntineoplastic Combined Chemotherapy ProtocolsCells, CulturedAcute DiseaseGraft RejectionCell SeparationMesenchymal Stromal CellsPluripotent Stem CellsMultipotent Stem CellsStem Cell FactorCell ProliferationOpportunistic InfectionsLymphoma, Non-HodgkinImmunosuppressionImmunocompromised HostLymphoproliferative DisordersOrgan TransplantationTransplantationHeart TransplantationPrognosisMice, SCIDLeukemia, Myeloid